經濟日報:從源頭遏制保險銷售誤導
格隆匯12月1日丨經濟日報文章指出,保險銷售誤導問題一直是保險監管中最重要的領域和難題之一。爲此,監管層多次發佈投保提示和保險銷售管理的各種規範要求,但問題始終不能根除,成爲保險行業衆所周知的頑疾。近日,一份由銀保監會人身險部下發的《人身保險銷售管理辦法(徵求意見稿)》眼下正在各保險公司管理層傳閱,內容涉及人身保險銷售管理內控、銷售活動、信息系統管理等方方面面。很顯然,進一步規範人身保險銷售監管是大勢所趨。《意見稿》將代理人分類管理與保險產品分級銷售相匹配,這將讓代理人分類管理定位更加清晰。只有保險代理人對產品理解和講解到位,保證消費者明明白白投保,纔可能最大限度降低銷售誤導,從源頭醫治保險業這一頑疾。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.